Edit
Polypeptide Therapeutic Solutions
https://pts-polypeptides.com/Last activity: 28.04.2021
Active
PTS speciallizes in the design and manufacturing of polyamino-acid based delivery systems and bring value to our delivering solutions to clinical development & commercialization of therapeutic assets.
PTS is a Leader in the design, development & Custom Manufacturing of polyaminoacid-based Drug Substances and Drug Products (DP). Our company provides a comprehensive CMC package, including Preclinical Development, Technology Transfer, GMP Manufacturing and Fill& Finish.
PTS is a Leader in the design, development & Custom Manufacturing of polyaminoacid-based Drug Substances and Drug Products (DP). Our company provides a comprehensive CMC package, including Preclinical Development, Technology Transfer, GMP Manufacturing and Fill& Finish.
Employees: 11-50
Founded date: 2012
Investors 1
| Date | Name | Website |
| 28.04.2021 | Arcline In... | arcline.co... |
Persons 17
| Date | First Name | Last Name | Title | Location | |||
| - | José Vicen... | Pons Andre... | - | linkedin.c... | - | i**o@pts-p... | - |
| - | Anna | Parra Sala... | Quality As... | linkedin.c... | - | a****a@pts... | - |
| - | Lidia | Herrera | Team Leade... | linkedin.c... | - | l******a@p... | - |
| - | Juan | Duato | Team Leade... | linkedin.c... | - | j****o@pts... | - |
| - | Amador | García San... | - | linkedin.c... | - | a*****a@pt... | - |
| - | Jose | Conejos Vi... | - | linkedin.c... | - | j******s@p... | - |
| - | Jaciel | Rabionet L... | Técnico de... | linkedin.c... | - | j*******t@... | - |
| - | Daniel | Morelló Bo... | - | linkedin.c... | - | d******o@p... | - |
| - | Eva | Martínez J... | Drug Produ... | linkedin.c... | - | e*******z@... | - |
| - | vicent J. | nebot | Chief Tech... | linkedin.c... | - | v****t@pts... | - |
Show more
Mentions in press and media 2
| Date | Title | Description |
| 28.04.2021 | Arcline Investment Management adquiere Polypeptide Therapeutic Solutions, participada por Columbus Venture Partners | 28/04/2021 Nota de prensa ARCLINE INVESTMENT MANAGEMENT ADQUIERE POLYPEPTIDE THERAPEUTIC SOLUTIONS, PARTICIPADA POR COLUMBUS VENTURE PARTNERS. Arcline Investment Management («Arcline«), una firma de private equity orientada al crecimient... |
| 16.02.2018 | ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-Resistant Bacteria | ABAC Therapeutics (ABAC), a leader in pathogen-specific antibiotics, announced today the closing of a €16 million Series A round. The financing was led by Pontifax with participation from the Global Health Science Fund (jointly established ... |